Advertisement
Loading...

ImmunoPrecise Antibodies Ltd.

IPA•NASDAQ
Healthcare
Biotechnology
$1.62
$0.04(2.53%)
U.S. Market opens in 39h 40m

ImmunoPrecise Antibodies Ltd. (IPA) Stock Overview

Explore ImmunoPrecise Antibodies Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap74.8M
P/E Ratio-8.49
EPS (TTM)$-0.66
ROE-0.63%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$2.39

IPA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ImmunoPrecise Antibodies Ltd. (IPA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.49 and a market capitalization of 74.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
2.53%
1-Month Change
2.53%
3-Month Change
-36.96%
6-Month Change
231.97%
Year-to-Date (YTD) Change
260.00%
1-Year Change
297.06%
3-Year Change
-69.83%
5-Year Change
-74.49%
All-Time (Max) Change
-63.01%

Contact Information

https://www.ipatherapeutics.com
250-483-0308
3204–4464 Markham Street, Austin, BC, V8Z 7X8

Company Facts

720 Employees
IPO DateJan 7, 2002
CountryCA

Frequently Asked Questions